Unicat
Unicat
Sex: F
Data Quality: 2 stars
MS: 10 yrs
Type: Relapsing-Remitting
Sensation: Moderate
Overall: Moderate
Cognition: moderate
Vision: moderate
Speech: moderate
Swallowing: moderate
Upper limb: moderate
Walking: moderate
Unicat
Female, 42 years
Two Rivers, WI
Primary Condition
MS and 2 more ▼
Type
Relapsing-Remitting
First symptom
May 2002
Diagnosis
Jul 2002
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

Unicat's Rebif is for:

  • MS

Unicat's side effects of Rebif:

Unicat's Rebif History (Stopped)
Rebif (interferon beta-1a subq injection)
44 mcg/0.5 mL Daily Apr 11, 2005 - Oct 20, 2011
Stopped Did not seem to work, Doctor's advice, and Other Oct 20, 2011
Evaluations
Date Dosage MS (Multiple Sclerosis) Efficacy Side Effects Adherence Burden
Oct 20, 2011 44 mcg/0.5 mL Daily Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_default MildMildMildMild UsuallyUsuallyUsuallyUsually SomewhatSomewhatSomewhatSomewhat
Dec 03, 2008 44 mcg/0.5 mL Daily Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_default ModerateModerateModerateModerate UsuallyUsuallyUsuallyUsually SomewhatSomewhatSomewhatSomewhat

About Rebif (Prescription Drug)

Rebif, a brand name for interferon beta-1a, is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It is given subcutaneously (under the skin) three times a week, ideally the same 3 days each week.

Learn more about Rebif in our Rebif Community Report.

Back to Unicat's Profile